Inicio Glosario Ar 11.1ª BIBLIOGRAFIA.
11.1ª BIBLIOGRAFIA.
Escrito por Dr. Jesús García Ruiz   

                                                                  

   Capítulo 1.   Concepto y etiopatogenia.

  • Bluestone CD. Role of Eustachian tube function in otitis media: current concepsts and relation to management. En: Eustachian tube function: physiology and role in otitis media. Ann Otol Rhinol Laryngol 1985;94 Supl 120:48-60. 
  • Campos MA, Arias A, Rodríguez C, et al. Etiología y tratamiento de las otitis supuradas crónicas. Journal of Chemoterapy 1995;7:427-431.
  • Flisberg K. Ventialroty studies on the Eustachian tube. A clinical investigation of cases with perforated ear drums. Acta POtolaryngol (Stockh) 1966;61:1-82.
  • Jung TT, Hanson JB. Classification of otitis media and surgical principles. Otolaryngol Clin North Am 1999; 32 (3): 369-83.
  • Niklitschek E, Segovia R. Prevalencia de otitis media crónica en población escolar, sector occidente de Santiago. Rev Otorrinolaringol Cir Cabeza Cuello 1999; 59: 65-71.
  • Schuknecht, H. Pathology of the Ear. Cambridge. Mass. Harvard University. Press 1976.
  • Senturia. BH; Paparella MM; Lowery HW; et al. Definition and clasification of Otitis media. Annals. Otol.Rhinol. Laryngol 1980-1989;Suppl 69: 4-8.
  • Thomsen VF, Olsen JS, Sorensen H, Thomsen J. Bacteriology and antibiotics in acute suppurative otitis media. J Otolaryngol. 1976;5(4):289-97. [PubMed] 

                                                 

   Capítulo 2.   Clínica, exploración y diagnóstico de la OMC simple.

  • Acuin J. Chronic suppurative otitis media. Clin Evid. 2006 Jun;(15):772-87. [PubMed]
  • Schuknecht HF. Pathology of the ear, 2.ª ed. Lea & Feabinger; 1993.
  • Swartz JD. Enfermedad inflamatoria otológica. En: Som PM, Thomas Bergeron R, editores. Edición española de Head and Neck imaging. Madrid: Mosby/Doyma; 1993. p. 993-1027.

                                                  

     Capítulo 3.   Tratamiento de la OMC simple.

  • Adler M, McDonald PJ, Trostmann U, Keyserling C, Tack K. Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. Pediatric Infectious Disease Journal 2000;19(Suppl 12):S166-S170.
  • Akisada T, Orita Y, Sato Y, Handa T, Yoshihiro T, Kawai A, Urabe Y, Aihara T, and Mori Y. Clinical evaluation of Sairei-to to chronic otitis media and cholesteatomas after tympanoplasty [Japanese]. Practica-Otologica 1997;92(Supplement):55-60.
  • Akisada T, Orita Y, Yoshihiro T, Kawai A, Urabe Y, Take K, Okumoto K, Hidaka T, Aihara T, and Hirai S. Clinical evaluation of Sairei-to for chronic otitis media and cholesteatoma after a tympanoplasty: Part II. [Japanese]. Practica Otologica 1998;98(Supplement):44-8.
  • Arguedas A, Herrera JF, Faingezicht I and Mohs E. Ceftazidime therapy for children with chronic suppurative otitis media without cholesteatoma. Pediatric Infectious Disease Journal 1993;12(3):246-8.
  • Arguedas.A.; Loaiza C. et all: Antimicrobial therapy for children with chronic suppurative otitis media without cholesteatoma.Pediatr.Infect.Dis.J. 1994;13(10):878-82.
  • Aslan A, Altuntas A, Titiz A, Arda HN, and Nalca Y. A new dosage regimen for topical application of ciprofloxacin in the management of chronic suppurative otitis media. Otolaryngology - Head and Neck Surgery 1998;118(6):883-5.
  • Bance M, Rutka JA. Topical treatment for otorrhea: issues and controversies. J Otolaryngol. 2005;34 Suppl 2:S52-5.
  • Block SL, McCarty JM, Hedrick JA, Nemeth MA, Keyserling CH, Tack KJ, and The Cefdinir Otitis Media Study Group. Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatric Infectious Disease Journal 2000;19(12 SUPPL):S159-S165.
  • Brook I and Shah K. Effect of amoxycillin with or without clavulanate on adenoid bacterial flora. Journal of Antimicrobial Chemotherapy 2001;48(2):269-73.
  • Browning GG, Picozzi GL, Calder IT, Sweeney G. Controlled trial of medical treatment of active chronic otitis media. British Medical Journal Clinical Research Edition 1983;287(6398):1024.
  • Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: A controlled study. Journal of Laryngology and Otology 1988;102(6):491-5.
  • Clayton MI, Osborne JE, Rutherford D, Rivron RP. A double-blind, randomized, prospective trial of a topical antiseptic versus a topical antibiotic in the treatment of otorrhea. Clinical Otolaryngology and Allied Sciences 1990;15(1):7-10.
  • Claes J, Govaerts PJ, Van Heyning et al. Lack of ciprofloxacin ototoxicity after repeated ototopical application. Antimicrobial Agents Chemoter 1991;35:1014-6. 
  • Coates H L, Morris P S, Leach A J, and Couzos S. Otitis media in Aboriginal children: Tackling a major health problem. Medical Journal of Australia 2002;177(4):177-8.
  • Coates H. Topical treatment of chronic suppurative otitis media in aboriginal children. Ear, Nose and Throat Journal 01 Aug 2003;82(Suppl. 8):13.
  • Consensus panel report. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngology-Head and Neck Surgery 2000; 122: 934-940. [Medline]
  • Chaput de Saintonge DM, Levine DF, Savage IT, Burgess GWS, Sharp J, Mayhew SR et al. Trial of three-day and ten-day courses of amoxycillin in otitis media. British Medical Journal Clinical Research Edition 1982;284(6322):1078-81.
  • Esposito S, D´Enrico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. Arch Otolaryngol Head Neck Surg 1990;116:557-9.
  • Esposito S, Novviello S, D´Enrico et al. Topical ciprofloxacin vd intramuscular gentamicin for chronic otitis media. Head Neck Surg 1992;118:1842-4.
  • Franki JE, Kirsti Dalimo et al. Contact allergy to various components of topical preparations for treatment of externa otitis. Acta Otolaryngol 1985;100:414-418.
  • García Rodriguez JA, García Sánchez JE, García García MI et al. Efficacy of topical ciprofloxacin in the treatment of ear infections in adults. J Antimicrob Chemoter 1993;31:452-3.
  • Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000;122(6):934-40.
  • Harada T, Iwamori M, Nagal Y, Nomura Y. Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol 1986;95:404-408.
  • Jahn AF, Abramson M. Medical managment of chronic otitis media. Otolaryngol Clin N Am 1984; 17: 673-678. [Medline] 
  • Macfadyen CA, Acuin JM, Gamble C. Tratamiento con antibióticos sistémicos versus tópicos para la secreción ótica crónica con perforación timpánica subyacente; 2005 (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd.
  • McPherson B, Swart SM. Childhood hearing loss in sub-Saharan Africa: a review and recommendations. International Journal of Pediatric Otorhinolaryngology 1997;40(1):1-18.
  • Manolidis S, Friedman R, Hannley M, Roland PS, Matz G, Rybak L, Stewart MG, Weber P, Owens F. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops. Otolaryngol Head Neck Surg. 2004;130 (3 Suppl):S83-8.
  • Maños M. La medicación tópica en otología. FMC 1998; 5: 203-209.Massias L, Buffe P, Cohen B, Cudennec Y, Gehanno Y, Sterkers O, Farinotti R. Study of the distribution of oral ciprofloxacin into the mucosa of the middle ear and the cortical bone of the mastoid process. Chemotherapy 1994;40:3-7.
  • Miguel de Martinez I, Vasallo Morillas JR, and Ramos Macias A. Terapeutica antimicrobiana en otitis media cronica supurada. Acta Otorrinolaringologica Espanola 1999;50(1):15-9.
  • Mira E, Benazzo M. Ceftizoxime as local therapy in the treatment of recurrences of chronic suppurative otitis media. Journal of Drug Development Supplement 1993;6(Suppl 2):39-44.
  • Mira E, Benazzo M. Uso Topico Delle Cefalosporine Nel Trattamento Delle Otiti Medie Purulente: Valutazione Della Ceftizoxima (Eposerin R)]. Rivista-Italiana-di-Otorinolaringologia-Audiologia-e-Foniatria 1992;12(4):219-25.
  • Papastavros T, Giamarellou H, Varlejides S. Preoperative therapeutic considerations in chronic suppurative otitis media. Laryngoscope 1989;99:655-9.
  • Pedersen NB. Allergy to chemical solutions for solft contact with ethyl alcohol. Contact dermatitis 1986;4:315.
  • Povedano Rodriguez V, Seco Pinero M, Jurado Ramos A, López Villarejo P. Eficacia del ciprofloxacino tópico en el tratamiento de la otorrea crónica. Acta Otorrinolaryngologica Española 1995;46(1):15-8.
  • Roland PS, Stewart MG, Hannley M, Friedman R, Manolidis S, Matz G et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: introduction, methodology, and recommendations. Otolaryngol Head Neck Surg 2004;130(3):51-56.
  • Senturia BH, Marcus MD, Lucente FE. Diseases of the External Ear 2ª ed Nueva Cork. Ed. Grune-Stratton. 1980.
  • Shah A, Amatya RCM, Tuldhar NR, Joshi MP. Tubotympanic chronic suppurative otitis media: Bacteriology and drug sensitivity. 2nd International SAARC ENT Congress. Extending ENT Servies to the Community. 2000:Abstract 37.
  • Shenderey K, Marsh BT, Talbot DJ. A multi-centre general practice comparison of a fixed-dose combination of pivmecillinam plus pivampicillin with amoxycillin in respiratory tract infections.  Pharmatherapeutica 1985;4(5):300-5.
  • Singh A, Georgalas C, Patel N, Papesch M. ENT presentations in children with HIV infection. Clinical Otolaryngology 2003;28:240-3.
  • Smith AW, Hatcher J, Mackenzie IJ, Thompson S, Bal I, Macharia I, Mugwe P, Okoth Olende C, Oburra H, Wanjohi Z. Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet 1996;348(9035):1128-33.
  • Somekh E, Cordova Z. Ceftazidime versus aztreonam in the treatment of pseudomonal chronic suppurative otitis media in children. Scandinavian Journal of Infectious Diseases 2000;32(2):197-9.
  • Stechenberg BW, Anderson D, Chang MJ, Dunkle L, Wong M, Van Reken D, Pickering LK, Feigin RD. Cephalexin compared to ampicillin treatment of otitis media. Pediatrics 1976;58(4):532-6.
  • Supiyaphun P, Kerekhanjanarong V, Koranasophonepun J, Sastarasadhit V. Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation. Journal of the Medical Association of Thailand 2000;83(1):61-8.
  • Shah A, Amatya RCM, Tuldhar NR, Joshi MP. Tubotympanic chronic suppurative otitis media: Bacteriology and drug sensitivity. 2nd International SAARC ENT Congress. Extending ENT Servies to the Community. 2000:Abstract 37.
  • Shenderey K, Marsh BT, Talbot DJ. A multi-centre general practice comparison of a fixed-dose combination of pivmecillinam plus pivampicillin with amoxycillin in respiratory tract infections. Pharmatherapeutica 1985;4(5):300-5.
  • Smith AW, Hatcher J, Mackenzie IJ, Thompson S, Bal I, Macharia I, Mugwe P, Okoth Olende C, Oburra H, Wanjohi Z. Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet 1996;348(9035):1128-33.
  • Somekh E, Cordova Z. Ceftazidime versus aztreonam in the treatment of pseudomonal chronic suppurative otitis media in children. Scandinavian Journal of Infectious Diseases 2000;32(2):197-9.
  • Stechenberg BW, Anderson D, Chang MJ, Dunkle L, Wong M, Van Reken D, Pickering LK, Feigin RD. Cephalexin compared to ampicillin treatment of otitis media. Pediatrics 1976;58(4):532-6. [Medline]
  • Yuen PW, Lau SK, Chau P, Hui Y, Wong SF, Wong S, Wei WI. Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study. American Journal of Otology 1994;15(5):670-3. [Medline]
Actualizado ( Miércoles, 26 de Mayo de 2010 11:50 )
 
Banner
Niños